feed,title,long_url,short_url
SeekingAlpha,NGM Biopharma price target cut by more than half at Raymond James after NASH setback,https://seekingalpha.com/news/3699568,
SeekingAlpha,Swiss Re: Favorable Industry Outlook Ahead But Pressures Remain,https://seekingalpha.com/article/4430922,
